Genomic Health, Inc. is the world's leading provider of genomic-based diagnostic tests that address both the overtreatment and optimal treatment of early stage cancer, one of the greatest issues in healthcare today. The company is applying its world-class scientific and commercial expertise and infrastructure to lead the translation of massive amounts of genomic data into clinically-actionable results for treatment planning throughout the cancer patient's journey, from screening and surveillance, through diagnosis, treatment selection and monitoring. Genomic Health's lead product, the Oncotype DX® breast cancer test, has been shown to predict the likelihood of chemotherapy benefit as well as recurrence in invasive breast cancer and has been shown to predict the likelihood of recurrence in ductal carcinoma in situ (DCIS). In addition to this widely adopted test, Genomic Health provides the Oncotype DX colon cancer test, the first multi-gene expression test developed for the assessment of risk of recurrence in patients with stage II and stage III disease, and the Oncotype DX prostate cancer test, which predicts disease aggressiveness in men with low risk disease. As of December 31, 2013, more than 19,000 physicians in over 70 countries had ordered approximately 420,000 Oncotype DX tests. The company is based in Redwood City, California with European headquarters in Geneva, Switzerland.
Genomic Health seeks exceptional professionals who share our commitment to improving the lives of people with cancer. As the world's leading provider of genomic cancer diagnostic tests, we are focused on using genomic information about a patient's individual tumor to personalize cancer treatment, and have built a world-class research, clinical and commercial organization to support this goal. We are looking to add highly skilled, dynamic, and collaborative individuals to our team who are passionate about shaping a world in which genomic information is truly life changing.
Genomic Health, Inc301 Penobscot Dr. Redwood City, CA 94063